A pattern of left ventricular hypertrophy evident on the electrocardiogram is a harbinger of morbidity and mortality from cardiovascular disease. Echocardiography permits the noninvasive determination of left ventricular mass and the examination of its role as a precursor of morbidity and mortality. We examined the relation of left ventricular mass to the incidence of cardiovascular disease, mortality from cardiovascular disease, and mortality from all causes in 3220 subjects enrolled in the Framingham Heart Study who were 40 years of age or older and free of clinically apparent cardiovascular disease, in whom left ventricular mass was determined echocardiographically. During a four-year follow-up period, there were 208 incident cardiovascular events, 37 deaths from cardiovascular disease, and 124 deaths from all causes. Left ventricular mass, determined echocardiographically, was associated with all outcome events. This relation persisted after we adjusted for age, diastolic blood pressure, pulse pressure, treatment for hypertension, cigarette smoking, diabetes, obesity, the ratio of total cholesterol to high-density lipoprotein cholesterol, and electrocardiographic evidence of left ventricular hypertrophy. In men, the risk factor-adjusted relative risk of cardiovascular disease was 1.49 for each increment of 50 g per meter in left ventricular mass corrected for the subject's height (95 percent confidence interval, 1.20 to 1.85); in women, it was 1.57 (95 percent confidence interval, 1.20 to 2.04). Left ventricular mass (corrected for height) was also associated with the incidence of death from cardiovascular disease (relative risk, 1.73 [95 percent confidence interval, 1.19 to 2.52] in men and 2.12 [95 percent confidence interval, 1.28 to 3.49] in women). Left ventricular mass (corrected for height) was associated with death from all causes (relative risk, 1.49 [95 percent confidence interval, 1.14 to 1.94] in men and 2.01 [95 percent confidence interval, 1.44 to 2.81] in women). We conclude that the estimation of left ventricular mass by echocardiography offers prognostic information beyond that provided by the evaluation of traditional cardiovascular risk factors. An increase in left ventricular mass predicts a higher incidence of clinical events, including death, attributable to cardiovascular disease.
Source Information
Framingham Heart Study, Mass. 01701.
This article has been cited by other articles:
Akar Bayram, N., Ciftci, B., Durmaz, T., Keles, T., Yeter, E., Akcay, M., Bozkurt, E.
(2008). Effects of continuous positive airway pressure therapy on left ventricular function assessed by tissue Doppler imaging in patients with obstructive sleep apnoea syndrome. Eur J Echocardiogr
0: jen257v1-7
[Abstract][Full Text]
Watkins, H, Ashrafian, H, McKenna, W J
(2008). The genetics of hypertrophic cardiomyopathy: Teare redux. Heart
94: 1264-1268
[Full Text]
Nagarajarao, H. S., Penman, A. D., Taylor, H. A., Mosley, T. H., Butler, K., Skelton, T. N., Samdarshi, T. E., Aru, G., Fox, E. R.
(2008). The Predictive Value of Left Atrial Size for Incident Ischemic Stroke and All-Cause Mortality in African Americans: The Atherosclerosis Risk in Communities (ARIC) Study. Stroke
39: 2701-2706
[Abstract][Full Text]
Kushwaha, S. S., Raichlin, E., Sheinin, Y., Kremers, W. K., Chandrasekaran, K., Brunn, G. J., Platt, J. L.
(2008). Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients. Eur Heart J
0: ehn407v1-9
[Abstract][Full Text]
Ainscough, J. F.X., Drinkhill, M. J., Sedo, A., Turner, N. A., Brooke, D. A., Balmforth, A. J., Ball, S. G.
(2008). Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction. Cardiovasc Res
0: cvn230v2-9
[Abstract][Full Text]
Verma, A., Meris, A., Skali, H., Ghali, J. K., Arnold, J. M. O., Bourgoun, M., Velazquez, E. J., McMurray, J. J.V., Kober, L., Pfeffer, M. A., Califf, R. M., Solomon, S. D.
(2008). Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial Infarction: The VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. J Am Coll Cardiol Img
1: 582-591
[Abstract][Full Text]
Konstam, M. A.
(2008). Patterns of Ventricular Remodeling After Myocardial Infarction: Clues Toward Linkage Between Mechanism and Morbidity. J Am Coll Cardiol Img
1: 592-594
[Full Text]
Fang, C. X., Dong, F., Thomas, D. P., Ma, H., He, L., Ren, J.
(2008). Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription. Am. J. Physiol. Heart Circ. Physiol.
295: H1206-H1215
[Abstract][Full Text]
Ruggenenti, P., Iliev, I., Costa, G. M., Parvanova, A., Perna, A., Giuliano, G. A., Motterlini, N., Ene-Iordache, B., Remuzzi, G., the BENEDICT Study Group,
(2008). Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT). Diabetes Care
31: 1629-1634
[Abstract][Full Text]
Biederman, R. W.W., Doyle, M., Young, A. A., Devereux, R. B., Kortright, E., Perry, G., Bella, J. N., Oparil, S., Calhoun, D., Pohost, G. M., Dell'Italia, L. J.
(2008). Marked Regional Left Ventricular Heterogeneity in Hypertensive Left Ventricular Hypertrophy Patients: A Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Cardiovascular Magnetic Resonance and Echocardiographic Substudy. Hypertension
52: 279-286
[Abstract][Full Text]
Sookoian, S, Gianotti, T F, Pirola, C J
(2008). Role of the C-344T aldosterone synthase gene variant in left ventricular mass and left ventricular structure-related phenotypes. Heart
94: 903-910
[Abstract][Full Text]
Niizeki, T., Takeishi, Y., Kitahara, T., Arimoto, T., Ishino, M., Bilim, O., Suzuki, S., Sasaki, T., Nakajima, O., Walsh, R. A., Goto, K., Kubota, I.
(2008). Diacylglycerol kinase-{varepsilon} restores cardiac dysfunction under chronic pressure overload: a new specific regulator of G{alpha}q signaling cascade. Am. J. Physiol. Heart Circ. Physiol.
295: H245-H255
[Abstract][Full Text]
Loyer, X., Gomez, A. M., Milliez, P., Fernandez-Velasco, M., Vangheluwe, P., Vinet, L., Charue, D., Vaudin, E., Zhang, W., Sainte-Marie, Y., Robidel, E., Marty, I., Mayer, B., Jaisser, F., Mercadier, J.-J., Richard, S., Shah, A. M., Benitah, J.-P., Samuel, J.-L., Heymes, C.
(2008). Cardiomyocyte Overexpression of Neuronal Nitric Oxide Synthase Delays Transition Toward Heart Failure in Response to Pressure Overload by Preserving Calcium Cycling. Circulation
117: 3187-3198
[Abstract][Full Text]
Grassi, G., Quarti-Trevano, F., Mancia, G.
(2008). Review: Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension. Journal of Renin-Angiotensin-Aldosterone System
9: 66-74
[Abstract]
Duncan, A. I., Lowe, B. S., Garcia, M. J., Xu, M., Gillinov, A. M., Mihaljevic, T., Koch, C. G.
(2008). Influence of concentric left ventricular remodeling on early mortality after aortic valve replacement.. Ann. Thorac. Surg.
85: 2030-2039
[Abstract][Full Text]
Foster, B. J., Mackie, A. S., Mitsnefes, M., Ali, H., Mamber, S., Colan, S. D.
(2008). A Novel Method of Expressing Left Ventricular Mass Relative to Body Size in Children. Circulation
117: 2769-2775
[Abstract][Full Text]
Chami, H. A., Devereux, R. B., Gottdiener, J. S., Mehra, R., Roman, M. J., Benjamin, E. J., Gottlieb, D. J.
(2008). Left Ventricular Morphology and Systolic Function in Sleep-Disordered Breathing: The Sleep Heart Health Study. Circulation
117: 2599-2607
[Abstract][Full Text]
Pavlopoulos, H., Grapsa, J., Stefanadi, E., Kamperidis, V., Philippou, E., Dawson, D., Nihoyannopoulos, P.
(2008). The evolution of diastolic dysfunction in the hypertensive disease. Eur J Echocardiogr
0: jen145v1-7
[Abstract][Full Text]
Alibin, C. P., Kopilas, M. A., Anderson, H. D. I.
(2008). Suppression of Cardiac Myocyte Hypertrophy by Conjugated Linoleic Acid: ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS {alpha} AND {gamma}. J. Biol. Chem.
283: 10707-10715
[Abstract][Full Text]
Frey, U. H., Lieb, W., Erdmann, J., Savidou, D., Heusch, G., Leineweber, K., Jakob, H., Hense, H.-W., Lowel, H., Brockmeyer, N. H., Schunkert, H., Siffert, W.
(2008). Characterization of the GNAQ promoter and association of increased Gq expression with cardiac hypertrophy in humans. Eur Heart J
29: 888-897
[Abstract][Full Text]
Bell, J. R., Porrello, E. R., Huggins, C. E., Harrap, S. B., Delbridge, L. M. D.
(2008). The intrinsic resistance of female hearts to an ischemic insult is abrogated in primary cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol.
294: H1514-H1522
[Abstract][Full Text]
Coffman, T. M., Crowley, S. D.
(2008). Kidney in Hypertension: Guyton Redux. Hypertension
51: 811-816
[Full Text]
Hill, J. A., Olson, E. N.
(2008). Cardiac Plasticity. NEJM
358: 1370-1380
[Full Text]
Scholz, D., Baicu, C. F., Tuxworth, W. J., Xu, L., Kasiganesan, H., Menick, D. R., Cooper, G. IV
(2008). Microtubule-dependent distribution of mRNA in adult cardiocytes. Am. J. Physiol. Heart Circ. Physiol.
294: H1135-H1144
[Abstract][Full Text]
Verburg, B. O., Jaddoe, V. W.V., Wladimiroff, J. W., Hofman, A., Witteman, J. C.M., Steegers, E. A.P.
(2008). Fetal Hemodynamic Adaptive Changes Related to Intrauterine Growth: The Generation R Study. Circulation
117: 649-659
[Abstract][Full Text]
Mayosi, B. M., Avery, P. J., Farrall, M., Keavney, B., Watkins, H.
(2008). Genome-wide linkage analysis of electrocardiographic and echocardiographic left ventricular hypertrophy in families with hypertension. Eur Heart J
29: 525-530
[Abstract][Full Text]
Mancia, G., Grassi, G.
(2008). Editorial: The new European Society of Hypertension/European Society of Cardiology (ESH/ESC) Guidelines. Therapeutic Advances in Cardiovascular Disease
2: 5-12
Woodcock, E. A., Du, X.-J., Reichelt, M. E., Graham, R. M.
(2008). Cardiac {alpha}1-adrenergic drive in pathological remodelling. Cardiovasc Res
77: 452-462
[Abstract][Full Text]
Frank, D., Kuhn, C., Brors, B., Hanselmann, C., Ludde, M., Katus, H. A., Frey, N.
(2008). Gene Expression Pattern in Biomechanically Stretched Cardiomyocytes: Evidence for a Stretch-Specific Gene Program. Hypertension
51: 309-318
[Abstract][Full Text]
Taniike, M., Yamaguchi, O., Tsujimoto, I., Hikoso, S., Takeda, T., Nakai, A., Omiya, S., Mizote, I., Nakano, Y., Higuchi, Y., Matsumura, Y., Nishida, K., Ichijo, H., Hori, M., Otsu, K.
(2008). Apoptosis Signal-Regulating Kinase 1/p38 Signaling Pathway Negatively Regulates Physiological Hypertrophy. Circulation
117: 545-552
[Abstract][Full Text]
Diwan, A., Wansapura, J., Syed, F. M., Matkovich, S. J., Lorenz, J. N., Dorn, G. W. II
(2008). Nix-Mediated Apoptosis Links Myocardial Fibrosis, Cardiac Remodeling, and Hypertrophy Decompensation. Circulation
117: 396-404
[Abstract][Full Text]
BAYLES, R. G., DAWOOD, T., LAMBERT, E. A., SCHLAICH, M. P., LAMBERT, G. W.
(2008). Elevated Cardiac Risk in Patients With Major Depressive Disorder. Am. J. Psychiatry
165: 137-137
[Full Text]
Chen, L., Zhang, J., Gan, T. X., Chen-Izu, Y., Hasday, J. D., Karmazyn, M., Balke, C. W., Scharf, S. M.
(2008). Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxia. J. Appl. Physiol.
104: 218-223
[Abstract][Full Text]
Desai, N. D., Christakis, G. T.
(2008). Bioprosthetic Aortic Valve Replacement: Stented Pericardial and Porcine Valves. Card Surg Adult
3: 857-894
[Full Text]
Strand, A., Kjeldsen, S.E., Gudmundsdottir, H., Os, I., Smith, G., Bjornerheim, R.
(2008). Tissue Doppler imaging describes diastolic function in men prone to develop hypertension over twenty years. Eur J Echocardiogr
9: 34-39
[Abstract][Full Text]
van den Brink, O. W., Delbridge, L. M D., Pedrazzini, T., Rosenfeldt, F. L, Pepe, S.
(2007). Augmented myocardial methionine-enkephalin in a murine model of cardiac angiotensin II-overexpression. Journal of Renin-Angiotensin-Aldosterone System
8: 153-159
[Abstract]
Iyem, H., Sekuri, C., Tavli, M., Buket, S.
(2007). Left Ventricular Hypertrophy and Remodeling after Aortic Valve Replacement. Asian Cardiovasc. Thorac. Ann.
15: 459-462
[Abstract][Full Text]
Rodriguez-Calvo, R., Serrano, L., Barroso, E., Coll, T., Palomer, X., Camins, A., Sanchez, R. M., Alegret, M., Merlos, M., Pallas, M., Laguna, J. C., Vazquez-Carrera, M.
(2007). Peroxisome Proliferator-Activated Receptor {alpha} Down-Regulation Is Associated With Enhanced Ceramide Levels in Age-Associated Cardiac Hypertrophy. J. Gerontol. A Biol. Sci. Med. Sci.
62: 1326-1336
[Abstract][Full Text]
Ferdinandy, P., Schulz, R., Baxter, G. F.
(2007). Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning. Pharmacol. Rev.
59: 418-458
[Abstract][Full Text]
Shimokawa, J., Yokoshiki, H., Tsutsui, H.
(2007). Impaired activation of ATP-sensitive K+ channels in endocardial myocytes from left ventricular hypertrophy. Am. J. Physiol. Heart Circ. Physiol.
293: H3643-H3649
[Abstract][Full Text]
Frank, D., Kuhn, C., van Eickels, M., Gehring, D., Hanselmann, C., Lippl, S., Will, R., Katus, H. A., Frey, N.
(2007). Calsarcin-1 Protects Against Angiotensin-II Induced Cardiac Hypertrophy. Circulation
116: 2587-2596
[Abstract][Full Text]
Meurrens, K., Ruf, S., Ross, G., Schleef, R., von Holt, K., Schluter, K.-D.
(2007). Smoking accelerates the progression of hypertension-induced myocardial hypertrophy to heart failure in spontaneously hypertensive rats. Cardiovasc Res
76: 311-322
[Abstract][Full Text]
Okin, P. M., Devereux, R. B., Harris, K. E., Jern, S., Kjeldsen, S. E., Lindholm, L. H., Dahlof, B., for the LIFE Study Investigators,
(2007). In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study. Hypertension
50: 984-990
[Abstract][Full Text]
Auchus, R. J., Drazner, M. H.
(2007). Will the Lessons From Primary Aldosteronism Change the Treatment of Hypertension and Left Ventricular Hypertrophy?. Hypertension
50: 837-839
[Full Text]
Schlaich, M. P., Lambert, G. W., Lambert, E. A., Esler, M. D.
(2007). Letter by Schlaich et al Regarding Article, "Relationship Between Central Sympathetic Drive and Magnetic Resonance Imaging-Determined Left Ventricular Mass in Essential Hypertension". Circulation
116: e416-e416
[Full Text]
Llamas, B., Belanger, S., Picard, S., Deschepper, C. F.
(2007). Cardiac mass and cardiomyocyte size are governed by different genetic loci on either autosomes or chromosome Y in recombinant inbred mice. Physiol. Genomics
31: 176-182
[Abstract][Full Text]
Daw, E. W., Chen, S. N., Czernuszewicz, G., Lombardi, R., Lu, Y., Ma, J., Roberts, R., Shete, S., Marian, A. J.
(2007). Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy. Hum Mol Genet
16: 2463-2471
[Abstract][Full Text]
Nielsen, O. W, Sajadieh, A.
(2007). Diagnosing left ventricular hypertrophy in arterial hypertension. BMJ
335: 681-682
[Full Text]
Lin, T.-H., Chiu, H.-C., Lee, Y.-T., Su, H.-M., Voon, W.-C., Liu, H.-W., Lai, W.-T., Sheu, S.-H.
(2007). Association Between Functional Polymorphisms of Renin-Angiotensin System, Left Ventricular Mass, and Geometry Over 4 Years in a Healthy Chinese Population Aged 60 Years and Older. J. Gerontol. A Biol. Sci. Med. Sci.
62: 1157-1163
[Abstract][Full Text]
Fox, E. R., Alnabhan, N., Penman, A. D., Butler, K. R., Taylor, H. A. Jr, Skelton, T. N., Mosley, T. H. Jr
(2007). Echocardiographic Left Ventricular Mass Index Predicts Incident Stroke in African Americans: Atherosclerosis Risk in Communities (ARIC) Study. Stroke
38: 2686-2691
[Abstract][Full Text]
Culleton, B. F., Walsh, M., Klarenbach, S. W., Mortis, G., Scott-Douglas, N., Quinn, R. R., Tonelli, M., Donnelly, S., Friedrich, M. G., Kumar, A., Mahallati, H., Hemmelgarn, B. R., Manns, B. J.
(2007). Effect of Frequent Nocturnal Hemodialysis vs Conventional Hemodialysis on Left Ventricular Mass and Quality of Life: A Randomized Controlled Trial. JAMA
298: 1291-1299
[Abstract][Full Text]
Burnier, M., Phan, O., Wang, Q.
(2007). High salt intake: a cause of blood pressure-independent left ventricular hypertrophy?. Nephrol Dial Transplant
22: 2426-2429
[Full Text]
Westerhout, C. M., Lauer, M. S., James, S., Fu, Y., Wallentin, L., Armstrong, P. W., for the GUSTO IV ACS Investigators,
(2007). Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women. Eur Heart J
28: 2064-2069
[Abstract][Full Text]
Strom Moller, C., Zethelius, B., Sundstrom, J., Lind, L.
(2007). Persistent ischaemic ECG abnormalities on repeated ECG examination have important prognostic value for cardiovascular disease beyond established risk factors: a population-based study in middle-aged men with up to 32 years of follow-up. Heart
93: 1104-1110
[Abstract][Full Text]
Williams, B.
(2007). Hypertension in the Young: Preventing the Evolution of Disease Versus Prevention of Clinical Events. J Am Coll Cardiol
50: 840-842
[Full Text]
Purcell, N. H., Wilkins, B. J., York, A., Saba-El-Leil, M. K., Meloche, S., Robbins, J., Molkentin, J. D.
(2007). Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proc. Natl. Acad. Sci. USA
104: 14074-14079
[Abstract][Full Text]
Lehmann, S., Walther, T., Kempfert, J., Leontjev, S., Rastan, A., Falk, V., Mohr, F. W.
(2007). Stentless Versus Conventional Xenograft Aortic Valve Replacement: Midterm Results of a Prospectively Randomized Trial. Ann. Thorac. Surg.
84: 467-472
[Abstract][Full Text]
Arias-Loza, P.-A., Hu, K., Dienesch, C., Mehlich, A. M., Konig, S., Jazbutyte, V., Neyses, L., Hegele-Hartung, C., Heinrich Fritzemeier, K., Pelzer, T.
(2007). Both Estrogen Receptor Subtypes, {alpha} and {beta}, Attenuate Cardiovascular Remodeling in Aldosterone Salt-Treated Rats. Hypertension
50: 432-438
[Abstract][Full Text]
McNiece, K. L., Gupta-Malhotra, M., Samuels, J., Bell, C., Garcia, K., Poffenbarger, T., Sorof, J. M., Portman, R. J.
(2007). Left Ventricular Hypertrophy in Hypertensive Adolescents: Analysis of Risk by 2004 National High Blood Pressure Education Program Working Group Staging Criteria. Hypertension
50: 392-395
[Abstract][Full Text]
Pieretti, J., Roman, M. J., Devereux, R. B., Lockshin, M. D., Crow, M. K., Paget, S. A., Schwartz, J. E., Sammaritano, L., Levine, D. M., Salmon, J. E.
(2007). Systemic Lupus Erythematosus Predicts Increased Left Ventricular Mass. Circulation
116: 419-426
[Abstract][Full Text]
Cheung, N., Bluemke, D. A., Klein, R., Sharrett, A. R., Islam, F.M. A., Cotch, M. F., Klein, B. E.K., Criqui, M. H., Wong, T. Y.
(2007). Retinal Arteriolar Narrowing and Left Ventricular Remodeling: The Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol
50: 48-55
[Abstract][Full Text]
Struthers, A., Lang, C.
(2007). The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent 'pancardiac' target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney. Eur Heart J
28: 1678-1682
[Abstract][Full Text]
Stakos, D. A, Schuster, D. P, Sparks, E. A, Meis, S. B., Wooley, C. F, Osei, K., Boudoulas, H.
(2007). Association between glycosylated hemoglobin, left ventricular mass and aortic function in nondiabetic individuals with insulin resistance. Eur J Endocrinol
157: 63-68
[Abstract][Full Text]
Yang, D. K., Choi, B. Y., Lee, Y.-H., Kim, Y.-G., Cho, M.-C., Hong, S.-E., Kim, D. H., Hajjar, R. J., Park, W. J.
(2007). Gene profiling during regression of pressure overload-induced cardiac hypertrophy. Physiol. Genomics
30: 1-7
[Abstract][Full Text]
Sabit, R., Bolton, C. E., Edwards, P. H., Pettit, R. J., Evans, W. D., McEniery, C. M., Wilkinson, I. B., Cockcroft, J. R., Shale, D. J.
(2007). Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med.
175: 1259-1265
[Abstract][Full Text]
Authors/Task Force Members:, , Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., Narkiewicz, K., Ruilope, L., Rynkiewicz, A., Schmieder, R. E., Struijker Boudier, H. A.J., Zanchetti, A., ESC Committee for Practice Guidelines (CPG):, , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., ESH Scientific Council:, , Kjeldsen, S. E., Erdine, S., Narkiewicz, K., Kiowski, W., Agabiti-Rosei, E., Ambrosioni, E., Cifkova, R., Dominiczak, A., Fagard, R., Heagerty, A. M., Laurent, S., Lindholm, L. H., Mancia, G., Manolis, A., Nilsson, P. M., Redon, J., Schmieder, R. E., Struijker-Boudier, H. A.J., Viigimaa, M., Document Reviewers:, , Filippatos, G., Adamopoulos, S., Agabiti-Rosei, E., Ambrosioni, E., Bertomeu, V., Clement, D., Erdine, S., Farsang, C., Gaita, D., Kiowski, W., Lip, G., Mallion, J.-M., Manolis, A. J., Nilsson, P. M., O'Brien, E., Ponikowski, P., Redon, J., Ruschitzka, F., Tamargo, J., van Zwieten, P., Viigimaa, M., Waeber, B., Williams, B., Zamorano, J. L.
(2007). 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J
0: ehm236v1-75
[Full Text]
Ingelsson, E., Sullivan, L. M., Murabito, J. M., Fox, C. S., Benjamin, E. J., Polak, J. F., Meigs, J. B., Keyes, M. J., O'Donnell, C. J., Wang, T. J., D'Agostino, R. B. Sr., Wolf, P. A., Vasan, R. S.
(2007). Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes. Diabetes
56: 1718-1726
[Abstract][Full Text]
Prasad, A. M., Ma, H., Sumbilla, C., Lee, D. I., Klein, M. G., Inesi, G.
(2007). Phenylephrine hypertrophy, Ca2+-ATPase (SERCA2), and Ca2+ signaling in neonatal rat cardiac myocytes. Am. J. Physiol. Cell Physiol.
292: C2269-C2275
[Abstract][Full Text]
Mehta, S. K., Rame, J. E., Khera, A., Murphy, S. A., Canham, R. M., Peshock, R. M., de Lemos, J. A., Drazner, M. H.
(2007). Left Ventricular Hypertrophy, Subclinical Atherosclerosis, and Inflammation. Hypertension
49: 1385-1391
[Abstract][Full Text]
Mitsuhashi, H., Yatsuya, H., Tamakoshi, K., Matsushita, K., Otsuka, R., Wada, K., Sugiura, K., Takefuji, S., Hotta, Y., Kondo, T., Murohara, T., Toyoshima, H.
(2007). Adiponectin Level and Left Ventricular Hypertrophy in Japanese Men. Hypertension
49: 1448-1454
[Abstract][Full Text]
Reudelhuber, T. L., Bernstein, K. E., Delafontaine, P.
(2007). Is Angiotensin II a Direct Mediator of Left Ventricular Hypertrophy?: Time for Another Look. Hypertension
49: 1196-1201
[Full Text]
Omland, T., Drazner, M. H., Ueland, T., Abedin, M., Murphy, S. A., Aukrust, P., de Lemos, J. A.
(2007). Plasma Osteoprotegerin Levels in the General Population: Relation to Indices of Left Ventricular Structure and Function. Hypertension
49: 1392-1398
[Abstract][Full Text]
Meyers, K. J., Mosley, T. H., Fox, E., Boerwinkle, E., Arnett, D. K., Devereux, R. B., Kardia, S. L.R.
(2007). Genetic Variations Associated With Echocardiographic Left Ventricular Traits in Hypertensive Blacks. Hypertension
49: 992-999
[Abstract][Full Text]
Fisch, S., Gray, S., Heymans, S., Haldar, S. M., Wang, B., Pfister, O., Cui, L., Kumar, A., Lin, Z., Sen-Banerjee, S., Das, H., Petersen, C. A., Mende, U., Burleigh, B. A., Zhu, Y., Pinto, Y. M., Liao, R., Jain, M. K.
(2007). Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy. Proc. Natl. Acad. Sci. USA
104: 7074-7079
[Abstract][Full Text]
Kuch, B., von Scheidt, W., Peter, W., Doring, A., Piehlmeier, W., Landgraf, R., Meisinger, C.
(2007). Sex-Specific Determinants of Left Ventricular Mass in Pre-Diabetic and Type 2 Diabetic Subjects: The Augsburg Diabetes Family Study. Diabetes Care
30: 946-952
[Abstract][Full Text]
S Zaman, M J., Sanders, J., Crook, A. M, Feder, G., Shipley, M., Timmis, A., Hemingway, H.
(2007). Cardiothoracic ratio within the "normal" range independently predicts mortality in patients undergoing coronary angiography. Heart
93: 491-494
[Abstract][Full Text]
Rame, J. E., Drazner, M. H., Post, W., Peshock, R., Lima, J., Cooper, R. S., Dries, D. L.
(2007). Corin I555(P568) Allele Is Associated With Enhanced Cardiac Hypertrophic Response to Increased Systemic Afterload. Hypertension
49: 857-864
[Abstract][Full Text]
Ammar, K. A., Jacobsen, S. J., Mahoney, D. W., Kors, J. A., Redfield, M. M., Burnett, J. C. Jr, Rodeheffer, R. J.
(2007). Prevalence and Prognostic Significance of Heart Failure Stages: Application of the American College of Cardiology/American Heart Association Heart Failure Staging Criteria in the Community. Circulation
115: 1563-1570
[Abstract][Full Text]
Sun, M., Chen, M., Dawood, F., Zurawska, U., Li, J. Y., Parker, T., Kassiri, Z., Kirshenbaum, L. A., Arnold, M., Khokha, R., Liu, P. P.
(2007). Tumor Necrosis Factor-{alpha} Mediates Cardiac Remodeling and Ventricular Dysfunction After Pressure Overload State. Circulation
115: 1398-1407
[Abstract][Full Text]
Fuentes, L. d. l., Brown, A. L., Mathews, S. J., Waggoner, A. D., Soto, P. F., Gropler, R. J., Davila-Roman, V. G.
(2007). Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J
28: 553-559
[Abstract][Full Text]
van de Schans, V. A.M., van den Borne, S. W.M., Strzelecka, A. E., Janssen, B. J.A., van der Velden, J. L.J., Langen, R. C.J., Wynshaw-Boris, A., Smits, J. F.M., Blankesteijn, W. M.
(2007). Interruption of Wnt Signaling Attenuates the Onset of Pressure Overload-Induced Cardiac Hypertrophy. Hypertension
49: 473-480
[Abstract][Full Text]
Elias, M. F., Sullivan, L. M., Elias, P. K., D'Agostino, R. B. Sr, Wolf, P. A., Seshadri, S., Au, R., Benjamin, E. J., Vasan, R. S.
(2007). Left Ventricular Mass, Blood Pressure, and Lowered Cognitive Performance in the Framingham Offspring. Hypertension
49: 439-445
[Abstract][Full Text]
Diwan, A., Dorn, G. W. II
(2007). Decompensation of Cardiac Hypertrophy: Cellular Mechanisms and Novel Therapeutic Targets. Physiology
22: 56-64
[Abstract][Full Text]
Kluck, O., Berman, M., Stamler, A., Sahar, G., Kogan, A., Porat, E., Sagie, A.
(2007). Value of echocardiography for stroke and mortality prediction following coronary artery bypass grafting. ICVTS
6: 30-34
[Abstract][Full Text]
De Castro, S., Caselli, S., Maron, M., Pelliccia, A., Cavarretta, E., Maddukuri, P., Cartoni, D., Di Angelantonio, E., Kuvin, J. T, Patel, A. R, Pandian, N. G
(2007). Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study. Heart
93: 205-209
[Abstract][Full Text]
Cooper, C. J., Murphy, T. P.
(2007). The Case for Renal Artery Stenting for Treatment of Renal Artery Stenosis. Circulation
115: 263-270
[Full Text]
McMullen, J. R., Amirahmadi, F., Woodcock, E. A., Schinke-Braun, M., Bouwman, R. D., Hewitt, K. A., Mollica, J. P., Zhang, L., Zhang, Y., Shioi, T., Buerger, A., Izumo, S., Jay, P. Y., Jennings, G. L.
(2007). Protective effects of exercise and phosphoinositide 3-kinase(p110{alpha}) signaling in dilated and hypertrophic cardiomyopathy. Proc. Natl. Acad. Sci. USA
104: 612-617
[Abstract][Full Text]
Chang, C.-C., Hung, C.-H., Chen, H.-L., Hwang, K.-L., Lin, C.-Y.
(2007). Peritoneal transport characteristics and dwelling time significantly impact ghrelin clearance in peritoneal dialysis patients. Nephrol Dial Transplant
22: 224-228
[Abstract][Full Text]
Maslov, M. Y., Chacko, V. P., Stuber, M., Moens, A. L., Kass, D. A., Champion, H. C., Weiss, R. G.
(2007). Altered high-energy phosphate metabolism predicts contractile dysfunction and subsequent ventricular remodeling in pressure-overload hypertrophy mice. Am. J. Physiol. Heart Circ. Physiol.
292: H387-H391
[Abstract][Full Text]
Previous
